Site Search
Professionals 883 results
Capabilities 90 results
Practice Area
Our Patent Litigation Practice is one of the country’s most active and highly regarded. Our seasoned patent litigators bring extensive courtroom experience to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022).
Practice Area
Securities, M&A & Corporate Governance Litigation
In today’s market, litigators with experience in securities, corporate governance, and M&A-related (collectively, “securities litigation”) matters need to leverage their broad experience to serve as both advocate and as counsel and strategist, focused on helping clients to overcome not just a legal issue but a collective business problem. Given the frequent interplay between things such as corporate-control transactions, public offerings, activist shareholders, the use of complex derivatives and other financial instruments, bad news impacting stock performance, regulatory inquiries and investigations, and insurance coverage, strategic and tactical litigation decisions can have a wide-ranging impact on the success of a given transaction, as well as on companies, their boards, senior management, and advisors.
Practice Area
Our attorneys have extensive experience counseling U.S. and multinational public companies across a range of industries in all aspects of corporate governance, securities, and compliance matters. We advise public companies, boards of directors and their committees, and senior executives on the corporate governance and compliance matters that public companies and their leadership confront—from board structuring and succession planning to shareholder activism and SEC regulation. Drawing on our experience as seasoned counselors, we keep clients abreast of evolving trends and best practices to proactively manage any governance or compliance issues. We have assembled one of the most experienced teams of any law firm in the country that’s counseling public companies.
Experience 162 results
Experience
|September 11, 2025
$1.5 Billion Raymond James Financial, Inc. Public Offering of Senior Notes
We served as underwriters' counsel to BofA Securities, Citigroup, J.P. Morgan and Raymond James, as joint book-running managers, in connection with the registered public offering of $1.5 billion of Senior Notes by Raymond James Financial, Inc. comprised of $650 million of its 4.900% Senior Notes due 2035, and $850 million of its 5.650% Senior Notes due 2055.
Experience
|September 10, 2025
$1.05 Billion PECO Energy Company Public Offering of First and Refunding Mortgage Bonds
We served as underwriters' counsel to BNY Capital Markets, Citigroup, PNC Capital Markets LLC, Scotiabank, US Bancorp, Mizuho and MUFG, as joint book-running managers, in connection with the registered public offering of $1.05 billion of First and Refunding Mortgage Bonds by PECO Energy Company comprised of $525 million 4.875% First and Refunding Mortgage Bonds due 2035 and $525 million 5.650% First and Refunding Mortgage Bonds due 2055.
Experience
|September 9, 2025
Winston & Strawn LLP represented Greenland Exploration Limited in a landmark business combination with Pelican Acquisition Corporation (NASDAQ: PELI) and March GL Company. The transaction, structured as a merger agreement, will result in the formation of Greenland Energy Company, expected to be publicly listed on NASDAQ under the ticker symbol “GLND.” Winston advised Greenland Exploration on all aspects of the deal, including regulatory strategy, corporate structuring, and negotiation of the merger terms.
Insights & News 5,631 results
Sponsorship
|October 22, 2025
Winston & Strawn Sponsors the 2025 Eastern District of Texas Bench Bar Conference
Winston & Strawn is a proud sponsor of the 2025 Eastern District of Texas Bench Bar Conference, one of the nation’s top annual bench bar conferences. The conference brings together judges, lawyers, topic speakers, guests, and other participants from across the world to discuss a broad range of cutting-edge legal topics.
MaritimeFedWatch
|October 20, 2025
|2 Min Read
China Retaliates Against U.S. Connected Vessels
On October 14, 2025, the U.S. Trade Representative imposed substantial fees on Chinese-built, otherwise Chinese-connected vessels, and most foreign-built vehicle carriers whether built in China or not. On the same day, the Chinese Ministry of Transport imposed retaliatory fees on “US vessels.”
In the Media
|October 20, 2025
|1 Min Read
Winston & Strawn associate William Logan was quoted in a Law360 article following a significant decision by the Texas Fifteenth Court of Appeals, which granted mandamus relief to nonparty patients seeking to protect their private medical records in a lawsuit concerning gender-affirming care. Winston represents the patients in opposing the State’s overly broad requests to secure their medical information. The appellate court directed a lower court to withdraw its order requiring two Dallas hospitals to produce documents related to the care of transgender patients, finding that the lower court had abused its discretion.
Other Results 123 results
Law Glossary
What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?
There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes relate to patent litigation.
Law Glossary
Colloquially referred to as the “patent dance,” the BPCIA provides a framework that includes certain steps and a schedule during which the applicant and reference product sponsor exchange confidential information disclosed in the aBLA. During the patent dance, the applicant and sponsor identify the patents that could be litigated in the future during two potential phases of litigation. In the first phase, the sponsor can allege infringement of a subset of the patents identified during the patent dance. The second phase begins after the sponsor receives the Notice of Commercial Marketing from the applicant. During this second phase, the sponsor can assert any remaining patents that were not asserted in the first phase.
Site Content